nav-left cat-right
cat-right

4th Ubiquitin Research and Drug Discovery Conferen...

Date: February 20-21, 2014 Venue: San Diego, CA This premier conference will host an exciting group of professionals from the academic, biotech, pharmaceutical, and business communities, and will focus on drug discovery aspects within the ubiquitin pathway. A balance of both academic and industry experts will facilitate discussion on the following areas: I. Deubiquitinating Enzymes as Drug Targets II. Novel Drug Targets in...

Food Processing and Technology 2013

OMICS Group invites all the participants across the globe to attend the 2nd International Conference and Exhibition on Food Processing and Technology during October 28-30, 2013 at Kansas city, USA. Food Processing and Technology-2013 is a remarkable event which brings together a unique and International mix of large and medium biotech and food diagnostic companies, leading universities and Nutritional institutes making the...

Cambridge Healthtech Institute Announces the Preli...

Programs discuss collecting and leveraging data to optimize clinical trials & operations, portals, data warehouses, and site & study execution metrics. Sixth Annual Electronic Data in Clinical Trials February 4-5, 2014 Hyatt Regency Miami, Miami, FL SCOPEsummit.com/Electronic-Data Third Annual Integrating and Leveraging Clinical Trial Operations Data February 5-6, 2014 Hyatt Regency Miami, Miami,...

Immune Pharmaceuticals Merges with EpiCept

Immune Pharmaceuticals and EpiCept have agreed to merge. The combined company, to be named Immune Pharmaceuticals, will be primarily focused on developing antibody therapeutics and other targeted drugs for the treatment of inflammatory diseases and cancer. Immune Pharmaceuticals is an Israel- and U.S.-based biopharmaceutical company focused on the development of next-generation antibody therapeutics addressing unmet...

BioCryst Halts Enrollment in Phase III Peramivir T...

BioCryst said today it halted patient enrollment in a Phase III trial of its flu drug candidate peramivir. In a statement, the company cited an interim analysis by its data monitoring committee that found just a small difference between peramivir and control groups for the primary endpoint, changes to vital signs and oxygen saturation through the 10th day. The company also cited the recalculation of its sample size,...

NMR Fine-Tuned for High-Content Metabolomics Scree...

Scientists report on the development of a nuclear magnetic resonance (NMR)-based method forscreening the metabolomic response of drug-treated mammalian cells to drug therapy. TheSanford-Burnham Medical Research Institute, and Rady Children’s Hospital investigators, say the highly sensitive, fast, and simple method is carried out in 96-well format, and could have particular utility as a method for high-throughput primary...
Page 10 of 34« First...89101112...2030...Last »